The Global Fund Program Coordination Unit (PCU) at the Ministry of Health (MOH) responsible to manage HIV, Tuberculosis and Malaria grants in Liberia has concluded a review of the Fund’s supported programs in the country. The review meeting was held on February 27, 2019 at the National Leprosy and Tuberculosis Control Program (NLTCP) in Congo Town, near Monrovia.
The meeting brought together more than 30 key stakeholders in the health sector, including representatives of the UN System, the government and local and international non-governmental organizations.
Welcoming the participants during the Joint Review meeting, Mrs. Sophie Parwon, Head of the Program Coordination Unit (MOH-PCU) said the Joint Review of the Global Fund grant implementation is undertaken to understand progress, constraints and future priorities. “As we come together today, let us discuss with open minds. Speak of the issues that matter most to the people at the community level. This will not only help the PRs but the country’s entire health system,” Mrs. Parwon averred.
The Joint Review provided all stakeholders an opportunity to discuss the progress on implementation of all principal recipients of the Global Fund grant in Liberia.
The PRs of the Global Fund grants for the period 2018-2020/21 are Ministry of Health for a joint Tuberculosis and HIV grant, Population Services International for HIV, and Ministry of Health and Plan International Liberia for Malaria and Health System Strengthening.
Principal Recipients (PRs) of the Global Fund grant delivered specific presentations on achievements, challenges and way forward to accelerating progress toward ending AIDS, increasing TB case notification and treatment of persons diagnosed of Tuberculosis, and reducing illnesses and deaths associated with Malaria in Liberia. The review covered the fourth quarter from October to December 2018.
Currently, Liberia’s HIV prevalence stands at 2.1%, according to the Liberia Demographic Health Survey (LDHS-2013); TB case notification is 5,849 reflecting the case detection rate of 41.8%, according to WHO 2014 estimate. Malaria prevalence also stands at 31% (LMIS 2016) with pregnant women and children under ages 5 being most at risk.
Comments are closed.